Podcasts about johns hopkins medical center

When Henrietta Lacks discovered a tumor inside of her in 1951, she turned to Johns Hopkins Medical Center for help. They examined her cells and discovered two things: First, she had cervical cancer. And second, her cells, for reasons we still can't explain, multiplied at astonishing rates, allowing doctors and pharmaceutical companies to use them to conduct all sorts of valuable research. Without Lacks knowledge or consent, her cells have been used to do amazing things, like create vaccinations for polio and HPV. But her case is most noteworthy for the ethical questions it forced us to face regarding medical consent, particularly within marginalized communities. "Crimes of the Centuries" is a podcast from Grab Bag Collab exploring forgotten crimes from times past that made a mark and helped change history. You can get early and ad-free episodes on the Grab Bag Patreon page.  DON'T FORGET ABOUT THE CRIMES OF THE CENTURIES BOOK!  Order today at www.centuriespod.com/book (https://www.centuriespod.com/book)! Follow us on Instagram and Twitter: @centuriespod Episode Sponsors: Storyworth. Give the dads in your life a unique, heartfelt gift you'll all cherish for years—Storyworth! Right now, save $10 during their Father's Day sale when you go to Storyworth.com/cotc Cornbread Hemp. Right now, Crimes Of The Centuries listeners can save 30% off their first order and enjoy free shipping on orders over $75! Head to cornbreadhemp.com/COTC and use code COTC at checkout.

Send us a textSend me a voicemail: speakpipe.com/longcovidmdIn this conversation, Dr. Khan discusses the impact of the autonomic nervous system in Long COVID, with Dr. Alba Azola, Assistant Professor of Physical Medicine and Rehabilitation at Johns Hopkins University.  Dr Azola explains the complexities of autonomic dysfunction, particularly focusing on dysautonomia and POTS, and how these conditions affect patients' daily lives. The discussion highlights the importance of a patient-centered approach in rehabilitation and the need for a multidisciplinary team to address the various symptoms and challenges faced by long COVID patients. In this conversation, Drs Azola and Khan delve into the complexities of dysautonomia, particularly in the context of long COVID and mast cell activation syndrome. They discuss the importance of understanding autonomic dysfunction, the role of mast cells in various symptoms, and the need for a collaborative healthcare approach. The conversation emphasizes non-pharmacologic interventions, the significance of tailored exercise programs, and the various medications available to manage symptoms. Ultimately, they highlight the importance of patient empowerment and finding healthcare providers who are willing to listen and collaborate.Dr Alba Azola, MD@HopkinsMECFSC@AzolaAlbaBioAssistant Professor, Departments of Rehabilitation and Physical Medicine and Pediatrics, Johns Hopkins Medical Center. Director of the Long COVID Chronic Fatigue Syndrome Clinic and Co-director of the JH-UTSW Brain Health Program. She is a co-investigator in several NIH, PCORI, and CDC-sponsored studies on Long COVID. As part of the AAPMR PASC collaborative, she has co-authored several guidance statements on managing Long COVID symptoms, including fatigue, dysautonomia, and cardiovascular complications.Subscribe for more at LongCovidMD.substack.com, and follow Dr Khan on X @doctor_zeest

Sofwave is the newest generation of non-surgical tightening for the skin in the face and neck. Ideal for younger patients who aren't quite ready for a facelift, Sofwave delivers ultrasound energy to tighten skin without the need for a long series of treatments. Unlike previous energy-based treatments, Sofwave gets the job done with fewer sessions and minimal discomfort.  Radiofrequency treatments typically involve a series of several treatments.  While also using sound energy, Ultherapy has a different exposure pattern compared with Sofwave.  Dr. Jason Pozner joins Dr. Bass in this 5th episode of our series “Lifting Without Cutting” to discuss the unique history of Sofwave and how it works. About Dr. Jason Pozner Jason Pozner, MD, is the co-founder and medical director of Sanctuary Medical Center in Boca Raton, Florida. Dr. Pozner was an assistant professor of plastic surgery at Johns Hopkins Medical Center in Maryland and currently serves as adjunct clinical faculty in the Department of Plastic Surgery at the Cleveland Clinic in Florida. Learn more about guest Dr. Jason Pozner https://www.spsboca.com/about/our-surgeons/dr-jason-pozner/ Check out Dr. Pozner's Instagram https://www.instagram.com/sanctuaryplasticsurgery/   About Dr. Lawrence Bass Innovator. Industry veteran. In-demand Park Avenue board certified plastic surgeon, Dr. Lawrence Bass is a true master of his craft, not only in the OR but as an industry pioneer in the development and evaluation of new aesthetic technologies. With locations in both Manhattan (on Park Avenue between 62nd and 63rd Streets) and in Great Neck, Long Island, Dr. Bass has earned his reputation as the plastic surgeon for the most discerning patients in NYC and beyond. To learn more, visit the Bass Plastic Surgery website or follow the team on Instagram @drbassnyc Subscribe to the Park Avenue Plastic Surgery Class newsletter to be notified of new episodes & receive exclusive invitations, offers, and information from Dr. Bass.   

Non-surgical skin tightening is the “holy grail” of plastic surgery, and Ellacor is the latest and greatest step toward it.  Since conducting the clinical trials for Ellacor, Florida plastic surgeon Dr. Jason Pozner has treated hundreds of patients – including himself!  By punching out numerous tiny cylinders of loose skin and stimulating the surrounding skin's healing response, Ellacor is designed to reduce laxity and generate healthier skin without leaving any scars. Dr. Pozner joins Dr. Bass to discuss what it does, how it works, and how it was developed. Listen as Drs. Bass and Pozner discuss downtime, aftercare, what they think about what it can and cannot do, and who the ideal patients are for this innovative new technology.  About Dr. Jason Pozner Jason Pozner, MD, is the co-founder and medical director of Sanctuary Medical Center in Boca Raton, Florida. Dr. Pozner was an assistant professor of plastic surgery at Johns Hopkins Medical Center in Maryland and currently serves as adjunct clinical faculty in the Department of Plastic Surgery at the Cleveland Clinic in Florida. Learn more about guest Dr. Jason Pozner Check out Dr. Pozner's Instagram About Dr. Lawrence Bass Innovator. Industry veteran. In-demand Park Avenue board certified plastic surgeon, Dr. Lawrence Bass is a true master of his craft, not only in the OR but as an industry pioneer in the development and evaluation of new aesthetic technologies. With locations in both Manhattan (on Park Avenue between 62nd and 63rd Streets) and in Great Neck, Long Island, Dr. Bass has earned his reputation as the plastic surgeon for the most discerning patients in NYC and beyond. To learn more, visit the Bass Plastic Surgery website or follow the team on Instagram @drbassnyc Subscribe to the Park Avenue Plastic Surgery Class newsletter to be notified of new episodes & receive exclusive invitations, offers, and information from Dr. Bass.   

In the wake of my father's recent cancer diagnosis, my focus has sharpened on the critical realm of early cancer detection. This unexpected event injected a surge of urgency into my unyielding quest for preventive wellness, leading me back to the brilliant Dr. Ahvie Herskowitz. Embark on a journey into preventive health as I reunite with Dr. Ahvie, the founder of Anatara Medicine, one of the most comprehensive IV treatment centers in Northern California. The multidisciplinary integrative center in San Francisco treats some of the most difficult chronic health conditions using a unique integrative approach and a host of modern medical technologies and tools. Dr. Ahvie is a former Clinical Professor of Medicine at UC San Francisco (UCSF) and the personal physician to some of the Bay Area's top biohackers, celebrities, actors, and longevity enthusiasts, along with a wide range of patients looking for eradication of issues like mold, spike protein, fungus, viral particles, and much more. His training includes a medical degree from The Albert Einstein College of Medicine and a Chief Residency in Anatomic Pathology and Internal Medicine, followed by fellowship training in cardiology at The Johns Hopkins Medical Center.  During his 12 years at Johns Hopkins, Dr. Ahvie was co-appointed in the Departments of Medicine and Molecular Immunology and Microbiology. His clinical responsibilities were complemented by directing a multidisciplinary NIH-sponsored research team in the study of molecular immunological and genomic mechanisms of inflammation and cell injury, autoimmunity, transplantation, congestive heart failure, and myocarditis. Today, Dr. Ahvie is back to impart his wealth of knowledge on colon cancer, spanning early detection methods, cancer screening, preventive remedies, and the vital role lifestyle and diet play in managing and preventing this condition. This episode promises a thought-provoking journey into the intricacies of colon health and its profound implications for overall well-being. Full show notes: https://bengreenfieldlife.com/cancerepisode Episode Sponsors: Essentia: Save an additional $100 on your mattress  with code BENVIP at myessentia.com/bengreenfield. LMNT: Go to DrinkLMNT.com/BenGreenfield to get a free gift with your purchase! Calroy: Visit calroy.com/ben save 20% when you bundle a 3-month supply of Arterosil HP. KetoMed: Visit ketomed.com/ben use code Ben40 for $40.00 off, free shipping, and no tax. FUM: Head to tryfum.com/BEN and use code BEN to save an additional 10% off.See omnystudio.com/listener for privacy information.

Episode 5: The Future of AI in Medicine: It's Already Here If you're a practitioner, click on the link for free credit: https://cmetracker.net/UTHSCSA/Publisher?page=pubOpen#/getCertificate/10095031 FACULTY: Khyzer Aziz, MD is the Associate Director of the Master of Science in Applied Health Sciences Informatics programs in Biomedical Informatics and Data Science. In addition, Dr. Aziz is the Director and Faculty/Scientific lead of the NICU Precision Medicine Center of Excellence (PMCOE) initiative at Johns Hopkins Medical Center. Dr. Khyzer Aziz's research interests are utilizing complex information found in the electronic medical record and national registries/databases to provide clear, cohesive, and concise information for patients, families, and clinicians that can be used for clinical decision-making and neonatal precision medicine.   OVERVIEW: Pediatrics Now Host and Executive Producer Holly Wayment interviews Johns Hopkins University's Khyzer Aziz, MD, a neonatologist and AI expert.   DISCLOSURES: Khyzer Aziz, MD has no financial relationships with ineligible companies to disclose.   The Pediatric Grand Rounds Planning Committee (Deepak Kamat, MD, PhD, Steven Seidner, MD, Daniel Ranch, MD and Elizabeth Hanson, MD) has no financial relationships with ineligible companies to disclose.    The UT Health Science Center San Antonio and Deepak Kamat, MD course director and content reviewer for the activity, have reviewed all financial disclosure information for all speakers, facilitators, and planning committee members; and determined and resolved all conflicts of interests.   CONTINUING MEDICAL EDUCATION STATEMENTS: The UT Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.   The UT Health Science Center San Antonio designates this live activity up to a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.   CREDITS: AMA PRA Category 1 Credits™ (0.50) Non-Physician Participation Credit (0.50)  

Dr. Preeti Raghavan is a Physical Medicine and Rehabilitation Physican who specializes in neurorehabilitation after stroke or brain injury. After completing her medical education in India, Dr. Raghavan trained at the Albert Einstein College of Medicine in the Bronx and Columbia University. She began her career at Mount Sinai School of Medicine, followed by Rusk Institute of Rehabilitation Medicine at New York University Langone Medical Center, and is now at Johns Hopkins Medical Center where she is a Professor of Stroke Treatment, Recovery, and Rehabilitation. She is an associate professor of physical medicine and rehabilitation and is a partner in a scientist founded start up called Mirrored Motion Works. She has published in both the brain injury and stroke rehabilitation literature. Her research interests include interventions to enhance motor recovery after stroke; development of novel technology and new treatments for muscle stiffness; emotional regulation and its interaction with recovery. In this episode we discuss stroke recovery across a variety of different impairments with an emphasis on physical recovery. In this episode we discuss:A typical stroke recovery timeline.Common concerns when recovering from a stroke.Specific impairments such as weakness, spasticity, neglect, and cognitive changes.Neuroplasticity.The podcast episodes drop weekly on Mondays in seasonal chunks. Subscribe to stay up to date, and tune in when you can! Be sure to rate, review, and follow on your favorite podcast app and let me know what other brain & body things you'd like to hear about.For more information about me, check out my website, www.natashamehtamd.com.Follow me on Instagram, Twitter, or Tik Tok @drnatashamehta.This episode is not sponsored.

As Toni King says, "What you don't know about Medicare is what can hurt you"! Also, Johns Hopkins Medical Center takes a great leap forward in coddling self-absorbed snowflakes. Contact me at: DBJ@MLMMailbag.com (Most severe critic: A+)   Inspired by: "MEDICARE FOR THE LAZY MAN 2023; Simplest & Easiest Guide Ever!" on Amazon.com. Return to leave a short customer review & help future readers. Official website: https://www.MedicareForTheLazyMan.com

Michael Halpern came on the show a few weeks back to explain the SPARS pandemic document that was released by Johns Hopkins Medical Center in conjunction with the Bloomberg School of Medicine in an episode that was so dangerous that Apple took it down. This episode digs even deeper into the document. The entire 89-page document can be found below in this description for those interested in reading it for themselves, but we decided to break it down page by page in this episode so that people can see the similarities between what was role-played back in 2017, and how things have actually transpired since then. Is this all just a giant coincidence or are we looking at the blueprint for a fake pandemic to be used as the pretext to remake society? Sponsors: Emergency Preparedness Food: www.preparewithmacroaggressions.com Chemical Free Body: https://www.chemicalfreebody.com and use promo code: MACRO C60 Purple Power: https://c60purplepower.com/ Promo Code: MACRO Wise Wolf Gold & Silver: www.Macroaggressions.gold True Hemp Science: https://truehempscience.com/ Haelan: https://haelan951.com/pages/macro Solar Power Lifestyle: https://solarpowerlifestyle.com/ Promo Code: MACRO Coin Bit App: https://coinbitsapp.com/?ref=0SPP0gjuI68PjGU89wUv Macroaggressions Merch Store: https://www.teepublic.com/stores/macroaggressions?ref_id=22530 LinkTree: linktr.ee/macroaggressions Books: HYPOCRAZY: https://amzn.to/3VsPDp8 Controlled Demolition on Amazon: https://amzn.to/3ufZdzx The Octopus Of Global Control: Amazon: https://amzn.to/3VDWQ5c Barnes & Noble: https://bit.ly/39vdKeQ Online Connection: Link Tree: https://linktr.ee/Macroaggressions Instagram: https://www.instagram.com/macroaggressions_podcast/ Discord Link:  https://discord.gg/4mGzmcFexg Website: www.theoctopusofglobalcontrol.com Facebook: www.facebook.com/theoctopusofglobalcontrol Twitter: www.twitter.com/macroaggressio3 Twitter Handle: @macroaggressio3 YouTube: www.youtube.com/channel/UCn3

In this episode, we get nostalgic. I talk with my good friend, Danie Leahy, who I met back in college when we worked on UVM Rescue together. When I was in medical school, I watched her match into Anesthesiology and she ultimately helped me choose the same specialty for myself. She has graduated residency and is currently doing a combined Cardiothoracic and Critical Care Fellowship at Johns Hopkins Medical Center. Listen along as we relive our rescue days and talk about what it's like being married to an anesthesiologist, why she chose her fellowship path, and how much she enjoys teaching. 00:08 Introduction 03:15 UVM Rescue Roots 09:45 Training Probies to Teaching Residents 12:00 Residency at UVM 16:00 Pandemic Pregnancy 23:15 Married to an Anesthesiologist 27:00 Decision to Pursue Fellowship 36:30 Future Job 39:15 What Makes Jobs Different 44:00 Proudest Moments So Far

This month, three African-American writers/activists with widely different political views published a book together entitled "Crisis in the Classroom" (Skyhorse Publishing). Despite their many differences, the authors teamed up to insist that the civil rights issue of today is the failure to educate young Americans. The three authors are Benjamin Crump, Esq., a prominent civil rights attorney whose clients have included George Floyd and Trayvon Martin, and who is sometimes called “Black America's Attorney General”; Dr. Benjamin Carson, who rose from poverty to head pediatric neurosurgery at Johns Hopkins Medical Center and later ran for President; and Armstrong Williams, an entrepreneur, philanthropist, and author of three earlier books who hosts “The Armstrong Williams Show,” which airs on Sinclair Broadcast Group TV stations across America. Williams joins Capital Research Center's Scott Walter to discuss the book and the crisis. This is part one in a two-part series. Links: Crisis in the Classroom: https://www.amazon.com/Crisis-Classroom-Dr-Benjamin-Carson/dp/1510776885 (https://www.amazon.com/Crisis-Classroom-Dr-Benjamin-Carson/dp/1510776885) How Government Worker Unions Manipulate Municipal Elections: https://capitalresearch.org/article/how-government-worker-unions-manipulate-municipal-elections/ Criticizing Teacher Union Allies? You Might Be A Domestic Terrorist: https://capitalresearch.org/article/criticizing-teachers-union-allies-you-might-be-a-domestic-terrorist/

In this wonderful conversation with my long-time friend and yoga service comrade, Pamela Stokes Eggleston, we discuss her experience with secondary trauma which she faced after taking care of her husband who returned from service with PTSD. We talk about the signs of trauma and how she's been able to take what she's learned to heal herself with yoga practice and help war veterans and their families. We also explore the importance of sleep and Pamela's core work helping folks to sleep better using the practice of yoga. Pamela Stokes Eggleston, MBA, MS, C-IAYT, E-RYT-500, YACEP is the founder and Director of Yoga2Sleep, Co-Founder of Retreat to Spirit, and Clinic Faculty at the Maryland University of Integrative Health (MUIH). She's a certified yoga therapist, meditation teacher, and end of life doula with specialized training in plant-based nutrition, cognitive behavioral therapy for insomnia (CBT-I), and trauma-informed yoga to work with service members, veterans, their caregivers, and insomnia sufferers. Pamela has a Master of Science in Yoga Therapy and a Master of Business Administration from the University of Maryland Global Campus. She has served on the board of the Accessible Yoga Association, the advisory board of Yoga Unify, the Grant Advisory Committee of the Yoga Alliance Foundation, and on the editorial board of the Journal of Applied Yoga Studies. An accomplished consultant, advisor, published author and international speaker, Pamela has worked for numerous agencies including the Substance Abuse and Mental Health Service Administration, the Veterans Administration, the Department of Labor, as a yoga therapy intern for Johns Hopkins Medical Center, and as an advisor on Congress-supported publications centering on substance abuse, mental health, criminal justice, and military and veteran family matters. Find Pamela at www.yoga2sleep.com and www.retreattospirit.today and on Instagram ----------------------------------------- Your support is deeply appreciated! Find me, Lara, on my Website / Instagram You can support this podcast with any level of donation here. Pre-order The Essential Guide to Trauma Sensitive Yoga: How to Create Safer Spaces for All Opening and Closing music: Other People's Photographs courtesy of Daniel Zaitchik. Follow Daniel on Spotify.

This month, three African-American writers/activists with widely different political views published a book together entitled "Crisis in the Classroom" (Skyhorse Publishing). Despite their many differences, the authors teamed up to insist that the civil rights issue of today is the failure to educate young Americans. The three authors are Benjamin Crump, Esq., a prominent civil rights attorney whose clients have included George Floyd and Trayvon Martin, and who is sometimes called “Black America's Attorney General”; Dr. Benjamin Carson, who rose from poverty to head pediatric neurosurgery at Johns Hopkins Medical Center and later ran for President; and Armstrong Williams, an entrepreneur, philanthropist, and author of three earlier books who hosts “The Armstrong Williams Show,” which airs on Sinclair Broadcast Group TV stations across America. Williams joins Capital Research Center's Scott Walter to discuss the book and the crisis. This is part one in a two-part series. Links: Crisis in the Classroom: https://www.amazon.com/Crisis-Classroom-Dr-Benjamin-Carson/dp/1510776885 (https://www.amazon.com/Crisis-Classroom-Dr-Benjamin-Carson/dp/1510776885) How Government Worker Unions Manipulate Municipal Elections: https://capitalresearch.org/article/how-government-worker-unions-manipulate-municipal-elections/ Criticizing Teacher Union Allies? You Might Be A Domestic Terrorist: https://capitalresearch.org/article/criticizing-teachers-union-allies-you-might-be-a-domestic-terrorist/

Description: Mil-Kid, Addison chats about her art piece, how it helped the family to celebrate life's moments even when her dad was deployed and about the challenges she faces as a military kid with type 1 diabetes and celiac. This podcast was made possible thanks to the generous support of the Offutt Officers Spouses Club. https://offuttosc.com/   Show Notes: Information on Diabetes https://diabetes.org/ Information on Juvenile Diabetes https://www.jdrf.org/ Information on Celiac Disease https://celiac.org/   Bio: Addison Richter Addison Richter is a US Army Active-Duty military child.  She is a rising seventh grader who epitomizes the word resilient.  Our family has endured 4 overseas deployments and multiple training rotations stateside.  Addi and her younger sister, Grace, have also been through 5 PCS moves. In her 6 years of schooling, Addi has attended 5 different schools.    In 2020, Addi was diagnosed with Type 1 Diabetes as Johns Hopkins Medical Center saved her life.  She was diagnosed with Celiac Disease 2 months later.  This kid doesn't let her multiple diagnoses define her.  She has played soccer for 9 years and is currently on a club travel soccer team with hopes of playing for the US Women's National Team in the future.  Addison has been involved with her school's student council and is a current fundraiser for Juvenile Diabetes Research Foundation. She is an honor roll student who uses art to celebrate her triumphs.  

Katie and Dixie speak with Professor Megan Hildebrandt whose unique life journey, which conjoined her artistic development with serious unexpected health issues, led her to become an "arts in healthcare advocate." Her experiential learning class, the Aesthetics of Health, won a Texas Tower award in 2021 and is a proving ground for the beneficial effects of artmaking in healthcare spaces. Thanks for joining us on The Other Side of Campus! ABOUT THE GUEST https://apps.jsg.utexas.edu/profiles/files/photos/megan_hildebrandt_thumb.jpg Megan Hildebrandt received her BFA from the Stamps School of Art & Design in 2006, and her MFA in Studio Art from the University of South Florida in 2012. Hildebrandt has exhibited widely, including: The Painting Center, New American Paintings, The Baltimore Museum of Art, The Museum of Contemporary Craft, Arlington Arts Center, Detroit Contemporary, Johns Hopkins Medical Center, the LIVESTRONG Foundation, Hyde Park Art Center, The Torpedo Factory, and The Painters Room. Hildebrandt has also recently had her writing on arts pedagogy during the pandemic published in Art Education, The Journal of the National Art Education Association. In 2018, Hildebrandt received an Art Works grant from the National Endowment for the Arts for the Aesthetics of Health Course she developed for Interlochen Arts Academy. An artist, educator, and arts-in-health advocate, Hildebrandt currently lives and works in Austin, Texas, where she is the Director of the First-Year Core Program in the Department of Art and Art History at The University of Texas. PRODUCER'S NOTE: This episode was recorded on October 8th, 2021 via Zoom. CREDITS Assistant Producers/Hosts: Dixie Stanforth and Katie Dawson (Intro theme features the following faculty in order: Jen Moon, Daron Shaw, Rich Reddick, Diane McDaniel Rhodes, Siobhan McCusker, Moriba Jah, and Stephanie Seidel Holmsten) Music by Charlie Harper (www.charlieharpermusic.com) Additional Background music by Charlie Harper, Scott Holmes, Ketsa, and Blue Dot Sessions Produced by Michelle S. Daniel Creator: Mary C. Neuburger Connect with us! Facebook: /texasptf Twitter: @TexasPTF Website: https://texasptf.org DISCLAIMER: The Other Side of Campus is a member of the Texas Podcast Network, brought to you by The University of Texas at Austin. Podcasts are produced by faculty members and staffers at UT Austin who work with University Communications to craft content that adheres to journalistic best practices. The University of Texas at Austin offers these podcasts at no charge. Podcasts appearing on the network and this webpage represent the views of the hosts, not of The University of Texas at Austin. https://files.fireside.fm/file/fireside-uploads/images/1/1ed1b736-a1fa-4ae4-b346-90d58dfbc8a4/4GSxOOOU.png Special Guest: Megan Hildebrandt.

Have you ever watched videos of cute babies online and then you start getting "baby fever"? And I believe that one of the monumental moments in our elementary education years is when we start learning about the actual process of this baby fever: "sexy time." As our guest described: "romantic" and "between sheets." However, there are instances when this activity does not result in the baby that the intending people wanted. According to the NIH, in the United States alone, approximately 9% of men and 11% of women of their reproductive age have infertility problems that imbue difficulties in the conception of a baby. Is there no longer hope for these partners to build the family that they have always dreamed of? Are there possible alternatives still available to them? There is no better person to ask these questions than the expert in the reproductive field: board-certified fertility expert physician Dr. Serena H. Chen.Receiving her bachelor's degree in Biology from Brown University in 1984, attaining her medical degree from Duke University in 1988, and completing her Obstetrics and Gynecology residency at Johns Hopkins Medical Center in 1992 where she also fulfilled her Reproductive Endocrinology/Infertility fellowship in 1995, Dr. Chen now stands as a fertility specialist and reproductive endocrinologist at Cooperman Barnabas Medical Center and IRMS Reproductive Medicine in New Jersey. Beyond this, she also served as a clinical associate professor at Rutgers New Jersey Medical School and St. George's University School of Medicine.With Dr. Chen's three decades of experience, we go into a deep dive into all things fertility and reproduction: the menstrual period, PCOS, infertility, miscarriages, ectopic pregnancies, ovarian reserve, Anti-Müllerian hormone, egg freezing, medical surrogacy, in vitro fertilization (IVF), LGBTQ+ family planning, and safety of vaccines for pregnant people. Through all of this, Dr. Chen has a clear message to those who want to become parents: in one way or another, there is hope for you to build a healthy and happy family so you should be informed of your options so you will have no regrets.Livestream Air Date: July 14, 2021Dr. Serena H. Chen: IG @drserenahchen, IRMS @ivf_irmsDr. Chen on WIRED: Fertility Expert Answers QuestionsFriends of Franz: IG @friendsoffranzpodChristian Franz (Host): IG @chrsfranz & YT Christian Franz

Our guests talk about how peers, friend-tors, and academic mentors can help you see potential in yourself that you may not have known. All this support is especially important to the success of minority and ethnic researchers who are looking to focus on a lung cancer specialty. “Mentors are those guiding lights that help us to progress to the next stage and to see paths where we may not have seen them before.” - Dr. Jarushka Naidoo Guests Dr. Jarushka Naidoo, a consultant medical oncologist at Beaumont Hospital in Dublin, Ireland who focuses on immunotherapy and is an LCFA Young Investigator Grant recipient Dr. David Tom Cooke, a cardiothoracic surgeon at the University of California Davis Health System specializing in cancer surgery Dr. Christian Rolfo, a thoracic oncologist who is associate director for clinical research in the Center for Thoracic Oncology/Tisch Cancer Institute, Mount Sinai, New York. Show Notes | Transcription Academic Mentors Help Make the Connections Academic mentors are necessary for advancing a researcher's career and accessing lung cancer research funding. There are a variety of approaches to mentoring and different mentors may bring different skills. A mentor can mean different things at different stages in your career. A mentor fundamentally means a teacher. Like teachers, a researcher needs a different type of teaching at different times in their careers. One of the things that is important about mentors is to realize that not all mentors are going to teach a researcher the same lessons, but the mentee will carry those lessons through their career. Some of the different kinds of mentors are: peer mentors – at your stage or a little bit senior to you who might teach you how to get things done friendtors – people who are at your stage and understand what you might need day-to-day. classic academic mentors – a senior mentor who has a bird's eye view of careers and how they can guide your career forward The Importance of Finding Academic Mentors “...it's important to establish a mentor, someone who introduces you to the scientific method from an early age, and guides you through a proper development pathway to understanding investigated research.” - Dr. David Tom Cooke You can take skills from mentors from different areas covering your needs, and giving you expertise in different fields. A good academic mentor can instill a genuine love for the specialty. They can help to navigate the interplay between understanding the different specialties that contribute to the world of oncology, and the true commitment to lifelong learning. How Lung Cancer Research Can Benefit From An Increase In Investigators From Minority And Ethnic Communities Researchers who bring a culturally sensitive perspective to lung cancer, can make a huge difference in research and in the communities they represent. As an underrepresented medicine physician, Dr. Cook understands in a culturally competent way, the mistrust of the healthcare system from the black and African American community. He can just sit down and talk with patients with that understanding. He can help to allay their fear of a clinical trial. In addition, Dr. Cook can help the healthcare institution understand how best to support these patients to promote them enrolling into clinical trials. Currently there is even more attention on the ability of a clinical study to attract and enroll under- engaged communities for a given research question. The grant applications are evaluated on how this research will reach out to underserved communities or underserved populations. Such as will women be enrolled in this trial? So, that is key to addressing questions about disparate populations and equal opportunities for participation. Thus a grant application will be evaluated based on these rules. Academic Mentors Help Navigate The Equity Space For Young Physicians Of course, many aspiring doctors do not attend the top rated University Medical School Programs, many of which are Ivy League schools. Many of the students who attend medical school programs at smaller schools may face unique challenges in their attempts to specialize in lung cancer research. And, the challenges are even greater for students from underrepresented minority groups. However, there is a misperception that investigative science and research only occurs at the Ivy League level. That misperception is not amongst researchers throughout this country and others, but mainly in the lay population. Looking at all National Cancer Institute Comprehensive Designated Cancer Centers, there are over 40 research universities. The majority of these facilities do not reside within the Ivy League environment. Look at the hundreds and hundreds of millions of dollars of research funds that goes into funding research, both in the public and private sector. The vast majority goes into other institutions, that include UC Davis Health and Johns Hopkins Medical Center. The key here is, if you are an individual, especially a person from an underrepresented medicine background, it's important to establish an academic mentor. Especially important, finding someone who introduces you to the scientific method from an early age. Then guides you through a proper development pathway to understanding investigated research. Academic Mentors and Research Funding There are also underutilized funding resources. Typically, resources may be underutilized because many people aren't aware of them. ​​Dr. Christian Rolfo stresses that it's very important that mentees to be very proactive. “Because if you are sitting there, even if you are coming from a big institution you are sitting there and you don't take the opportunities, nobody will knock your door.” Dr. Cooke believes the key is cross demographic mentorship. An academic mentor doesn't have to look like you or come from the same background, or even quite frankly be in the same political persuasion. But they have to have faith in your abilities, and their only goal in mentoring you, is seeing your success. For example Dr. Cooke cited one of his earliest academic mentors, Dr. Marion Katchlin. “She was older, I was younger, she was wealthy, I was not. She was a smoker, I wasn't. But we both loved immunology. And she took a specific interest in my career, and she taught me that I shouldn't limit myself in any way, and I should strive for the best in any opportunity I want to strive for.” Resources How an LCFA/IASLC Grant Benefits Lung Cancer Research LCFA Research Grants How to find funding for lung cancer research

Guest Panelist: Dr. Alisa Coker, Robotic Surgery Specialist at Johns Hopkins Medical Center in Baltimore, Maryland, USA.This week, the topic of discussion was: Robotic Surgery Ventral Hernia Repair Incisional Hernia Repair Mesh rIPT Robotic Iliopubic Tract Repair Laparoscopic Surgery Robotic Malfunction Hernia Repair Open Hernia Surgery Plug Mesh Large HerniasHerniaTalk LIVE is a Q&A hosted by Dr. Shirin Towfigh, hernia and laparoscopic surgery specialist who practices at the Beverly Hills Hernia Center. This is the only Q&A of its kind, aimed at educating and empowering patients about all things related to hernias and hernia-related complications. For a personal consultation with Dr. Towfigh: +1-310-358-5020, info@beverlyhillsherniacenter.com.If you find this content informative, please LIKE, SHARE, and SUBSCRIBE to the HerniaTalk Live channel and visit us on www.HerniaTalk.com.Follow Dr. Towfigh on the following platforms:Youtube | Facebook | Instagram | Twitter

Michael Halpern came on the show a few weeks back to explain the SPARS pandemic document that was released by Johns Hopkins Medical Center in conjunction with the Bloomberg School of Medicine in an episode that was so dangerous that Apple took it down. This episode digs even deeper into the document. The entire 89-page document can be found below in this description for those interested in reading it for themselves, but we decided to break it down page by page in this episode so that people can see the similarities between what was role-played back in 2017, and how things have actually transpired since then. Is this all just a giant coincidence or are we looking at the blueprint for a fake pandemic to be used as the pretext to remake society?Sponsors: Emergency Preparedness Food: www.preparewithmacroaggressions.com for $100 off a 4-week supply of food.Chemical Free Body: https://www.chemicalfreebody.com and use promo code: MACRO Honey Colony: https://www.honeycolony.com and use promo code: MACROC60 Purple Power: https://c60purplepower.com/Promo Code: MACRO Coin Bit App: https://coinbitsapp.com/?ref=0SPP0gjuI68PjGU89wUvMacroaggressions Merch Store:https://www.teepublic.com/stores/macroaggressions?ref_id=22530 Books:Controlled Demolition on Amazon: https://www.amazon.com/dp/B08M21XKJ5Purchase "The Octopus Of Global Control"Amazon: https://amzn.to/3aEFFcrBarnes & Noble: https://bit.ly/39vdKeQOnline Connection: Website: www.theoctopusofglobalcontrol.com Facebook: www.facebook.com/theoctopusofglobalcontrolTwitter: www.twitter.com/macroaggressio3Twitter Handle: @macroaggressio3YouTube: www.youtube.com/channel/UCn3GlVLKZtTkhLJkiuG7a-QApple Podcasts: https://apple.co/2LjTwu5

Alicia Wilson serves as the Vice President of economic development at Johns Hopkins Medical Center. Shelly and Alicia discuss diversity in Corporate America and what it really means to get a seat at the table. She explains what economic development means to her and how you can be philanthropic at any level and at any age.

Several key research studies have pointed to the potential links of hearing loss and Dementia, including the groundbreaking work from Dr. Lin and his colleagues at Johns Hopkins Medical Center that indicated hearing loss can increase the risk of Dementia by 200-500%. In a recent study, Dr. Jamie Desjardins, PhD, (University of Texas at El Paso), demonstrated that today's current hearing loss treatment options can improve brain function in people with hearing loss. This is a special two part episode of ABHA Listen & Learn. We have the great opportunity to speak with Dr. Jill Davis, audiologist from Texas and former student resident at ABHA. PART TWO: Our discussions with Dr. Jill Davis continues as we learn more about the link between Dementia and hearing loss. MUSIC PICK: "Colors" - Black Pumas https://www.youtube.com/watch?v=B7PnQBn5k_E CONTACT: questions@arizonabalance.com 602-265-9000 www.azbalanceandhearing.com SPONSOR: https://www.cognivue.com/

Dr. Albert Garcia-Romeu discusses his research at Johns Hopkins Medical Center involving Psilocybin and its potential in treating multiple mental health disorders. We discuss the state of the field and potential future directions. Research Assistants Sam Nidorf and Austin Asa guest co-host.

In this episode we sit down with former Centrum resident, Megan Hildebrandt, who exudes humor, care, and generosity as she shares stories of the various shifts in her life and the ways that cancer and parenting have impacted her work over the years. Megan Hildebrandt received her BFA from the Stamps School of Art & Design in 2006, and her MFA in Studio Art from the University of South Florida in 2012. Hildebrandt has exhibited nationally and internationally, including: The Painting Center, New American Paintings, The Baltimore Museum of Art, The Museum of Contemporary Craft, Arlington Arts Center, Detroit Contemporary, HEREarts Center, Latitude 53, Johns Hopkins Medical Center, the LIVESTRONG Foundation, Hyde Park Art Center, The Torpedo Factory, and The Painter’s Room. In 2018, Hildebrandt received an Art Works grant from the National Endowment for the Arts for the Aesthetics of Health Course she developed for Interlochen Arts Academy. An artist, educator, and arts-in-health advocate, Hildebrandt currently lives and works in Austin, Texas, where she is Associate Professor of Practice in the Department of Art and Art History at The University of Texas. See more of Hildebrandt’s work at https://www.meganlynnhildebrandt.com/

Rabbi Mark S. Golub reviews some of the latest findings of the CDC and Johns Hopkins Medical Center regarding the ways in which the Covid virus does and does not spread, as well as states’ ending lockdown, and reads viewer Mazal Tov’s.

Join us as we begin our investigation into behavior and behavior remediation in education with special guest, Dr. Michael Hart.NOTE: This episode references visuals. Please visit the Podcasts tab on our website to find the visuals and follow along.In this episode of Mentorships in Education, we welcome Dr. Michael Hart. Mentorships in Education is brought to you by Just Education, LLC and is hosted by Judith Epstein. Judith has a Master's degree in Education with a concentration in Language Acquisition. She is certified in special education with post-graduate coursework and professional development in Cognitive Behavior Therapy (CBT), Social Thinking, and Collaborative & Proactive Solutions and Acceptance and Commitment therapy (ACT). Judith created Just Education, LLC to compile a free resource library for mentors of students who struggle on a wide variety of topics that are all related to education and student success.Michael Hart, Ph.D has more than 25 years of experience as an international literacy expert, entrepreneur, and consultant. Dr. Hart’s unique background provides him with the authority and expertise to challenge the status quo of global literacy initiatives and lead the charge in providing new solutions.After completing a Ph.D. in Psychology, Dr. Hart began his career as a child psychologist, practicing in diverse psychiatric treatment settings that included working with primary and secondary school students. As his career progressed, he developed an expertise in learning challenges and attention issues. In fact, his passion for understanding neurologically-based processing problems drove him to further his research under the mentorship of top psychologists at renowned institutions, including Philadelphia Child Guidance Clinic at the University of Pennsylvania Hospital and the Kennedy Krieger Institute at Johns Hopkins Medical Center. Dr. Hart went on to receive a Master of Business Administration (MBA) degree from the University of Pennsylvania’s Wharton School.Dr. Hart’s work is used by some of the leading international organizations focused on moving the needle in society’s understanding of learning differences. Some of his most notable achievements include:Recent co-chair of UNESCO’s Mahatma Gandhi Institute of Education for Peace and Sustainable Development (MGIEP) advisory committee, which oversees a large-scale literacy development project across India.Literacy Expert for Understood.org, one of the largest global repositories of information on learning and attention issues.Founding board member of TEDxNashville and chair of speaker selection committee for over four years.Dr Hart may be reached through LinkedIn or at doctormichaelhart@gmail.com - will address and concerns or questions.RESOURCES & LINKS MENTIONED IN THIS EPISODE:Wrightslaw https://www.wrightslaw.com/ Margie Gillis www.literacyhow.com www.understood.orgYale Center for dyslexia and creativity: http://dyslexia.yale.edu/?gclid=CNum-5KNy7cCFUdk7Aod0g4ADwDyslexia Help at Univeristy of Michigan: http://dyslexiahelp.umich.edu/professionals/dyslexia-school/strategies-for-teachersCONNECT WITH USEmail Judi: info@justeducationfirst.comOur Website: http://justeducationfirst.comJudi on Linkedin: https://www.linke

Whether you bike or hike, run or climb, swim or paddle, or however you stay in shape, join us for the Spring Training edition of What Hurts Today? , our seasonal focus on fitness and exercise with Dr. Miho Tanaka. The acclaimed orthopedic surgeon and sport-fitness expert is the founder and former director of the Women's Sports Medicine Program at the Johns Hopkins Medical Center. Now, she is moving to Boston, where she will be directing the same program at the city's Massachusetts General Hospital, and teaching orthopedic surgery at the Harvard Medical School. But today, Dr. Tanaka joins us to answer your questions about avoiding and coping with athletic injuries and the best ways to stay fit this season. This conversation was live-streamed on Facebook, and you can watch the video on the WYPR Facebook page.

Jane:                                     Hi, everyone. Welcome to Episode 18 of Getting Personal: Omics of the Heart. I'm Jane Ferguson, and this podcast is brought to you by the Circulation: Genomic and Precision Medicine Journal and the American Heart Association Counsel on Genomic and Precision Medicine. It is July 2018, which means that the best possible place to be listening to this episode is at the beach, but failing that I can also recommend listening on planes, during your commute, while exercising or while drinking a nice cup of tea.                                                 So before I get into the papers we published this month, I want to ask for your help. If you're listening to this right now, hi, that means you, we're a year and a half into podcasting and I would love to know what content you like and where we could improve things. We have a poll up on Twitter this week, and I would really appreciate your input. If you're listening to this a little bit later and miss the active voting part of the poll, you can still leave suggestions.                                                 Okay, so what I would like you to do right now is to go to Twitter. You can find us as Circ_Gen and locate the poll. If you don't already follow us on Twitter, go do that now too. We want you to let us know what content we should focus on and what is most useful to you, so go ahead and pick your favorites from the options and also please reply or tweet at us with other thoughts and suggestions.                                                 Options include giving summaries of the recent articles like I'm about to do later this episode, conducting interviews with authors of recently published papers, interviews with people working in cardiovascular genomics, broader topics. For example, to get their insight on career paths and lessons learned along the way.                                                 And something we have not done yet on the podcast but are considering, would be to record podcasts that focus on particular topics in genomics and precision medicine. These could give some background on an emerging field or technology and we could talk to experts who are leading particular innovations in the field. So, if that sounds good to you, let me know! If you're not on Twitter, I don't want to exclude you, so you can email me at jane.f.ferguson@vanderbilt.edu and give me your thoughts that way. I'm looking forward to hearing from you.                                                 Okay, so on to the July 2018 issue of Circ.: Genomic and Precision Medicine. First up is a PhWAS from Abrahim Rao, Eric Ingelsson, and colleagues from Stanford. The discovery of the PCSK9 gene as a regulator of cholesterol levels has led to a new avenue of LDL lowering therapies through PCSK9 inhibition. However, some studies suggest that long term use of PCSK9 inhibitors could have adverse consequences. Because of the long follow-up time required, it will take many more years to address this question through clinical studies. However, genetic approaches offer a fast and convenient alternative to address the issue.                                                 In this paper, entitled: "Large Scale  Phenome-Wide Association Study of PCSK9 Variants Demonstrates Protection Against Ischemic Stroke," the authors use genetic and phenotype data from over 300,000 individuals in the UK BioBank to address whether genetic loss of function variants in PCSK9 are associated with phenotypes including coronary heart disease, stroke, type II diabetes, cataracts, heart failure, atrial fibrillation, epilepsy, and cognitive function.                                                 The missense variant RS11591147 was associated with protection against coronary heart disease and ischemic stroke. This SNP also associated with type II diabetes after adjustment for lipid medication status. Overall, this study recapitulated the associations between PCSK9 and coronary disease, and revealed an association with stroke.                                                 Previous studies suggested use of LDL lowering therapies may increase risk of cataracts, epilepsy, and cognitive dysfunction, but there was no evidence of association in this study. Overall, this study provides some reassurance that the primary effect of PCSK9 is on lipids and lipid related diseases, and that any effects on other phenotypes appear to be modest at best. While a PhWAS can't recapitulate a clinical trial, what this study indicates is that PCSK9 inhibition is an effective strategy for CVD prevention, which may confer protection against ischemic stroke and does not appear to convey increased risk for cognitive side effects.                                                 Next up we have a manuscript form Jason Cowan, Ray Hershberger, and colleagues from Ohio State University College of Medicine. Their paper, "Multigenic Disease and Bilineal Inheritance in Dilated Cardiomyopathy Is Illustrated in Non-segregating LMNA Pedigrees," explored pedigrees of apparent LMNA related cardiomyopathy identifying family members who manifested disease, despite not carrying the purported causal LMNA variant. Of 19 pedigrees studies, six of them had family members with dilated cardiomyopathy who did not carry the family's LMNA mutation. In five of those six pedigrees, the authors identified at least one additional rare variant in a known DCM gene that was a plausible candidate for disease causation.                                                 Presence of additional variants was associated with more severe disease phenotype in those individuals. Overall, what this study tells us is that in DCM, there is evidence for multi-gene causality and bilineal inheritance may be more common than previously suspected. Future larger studies should consider multi-genic causes and will be required to fully understand the genetic architecture of DCM.                                                 Yukiko Nakano, Yasuki Kihara, and colleagues from Hiroshima University published a manuscript detailing how HCN4 gene polymorphisms are associated with tachycardia inducted cardiomyopathy in patients with atrial fibrillation. Tachycardia induced cardiomyopathy is common in subjects with atrial fibrillation, but the pathophysiology is poorly understood. Recent studies have implicated the cardiac hyperpolarization activated cyclic nucleotide gated channel gene, or HCN4, in atrial fibrillation and ventricular function.                                                 In this paper, the authors enrolled almost 3,000 Japanese subjects with atrial fibrillation, both with and without tachycardia-induced cardiomyopathy, as well as non-AF controls. They compared frequency of variants in HCN4 in AF subjects with or without tachycardia-induced cardiomyopathy, and found a SNP, RS7164883, that may be a novel marker of tachycardia-induced cardiomyopathy in atrial fibrillation.                                                 Xinyu Yang, Fuli Yu, and coauthors from Tianjin University were interested in finding causal genes for intracranial aneurysms, and report their results in a manuscript entitled, "Rho Guanine Nucleotide Exchange Factor ARHGEF17 Is a Risk Gene for Intracranial Aneurysms." They sequenced the genomes of 20 Chinese intracranial aneurysm patients to search for potentially deleterious, rare, and low frequency variants. They found a coding variant in the ARHGEF17 gene which was associated with associated with increased risk in the discovery sample, and which they replicated in a sample of Japanese IA and in a larger Chinese sample.                                                 They expanded this to other published studies, including individuals of European-American and French-Canadian origin and found a significantly increased mutation burden in ARHGEF17 in IA patients across all samples. They were interested in further functional characterization of this gene and found that Zebra fish ARHGEF17 was highly expressed in blood vessels in the brain. They used morpholinos to knock down ARHGEF17 in Zebra fish, and found that ARHGEF17 deficient Zebra fish developed endothelial lesions on cerebral blood vessels, and showed evidence of bleeding consistent with defects in the vessel. This study implicates ARHGEF17 as a cerebro-vascular disease gene which may impact disease risk through effects on endothelial function and blood vessel stability.                                                 Sumeet Khetarpal, Paul Babb, Dan Rader, Ben Voight, and colleagues from the University of Pennsylvania used targeted resequencing to look at determinants of extreme HDL cholesterol in their aptly titled manuscript, "Multiplexed Targeted Resequencing Identifies Coding and Regulatory Variation Underlying Phenotypic Extremes of HDL Cholesterol in Humans." Stay tuned because we're gonna hear more about this paper from the first author Dr. Sumeet Khetarpal later this episode.                                                 Rounding out this issue we have a Perspective article from Chris Haggerty, Cynthia James, and coauthors from Geisinger and Johns Hopkins Medical Center entitled, "Managing Secondary Genomic Findings Associated With Arrhythmogenic Right Ventricular Cardiomyopathy: Case Studies and Proposal for Clinical Surveillance." In this paper the authors discuss the challenges for returning findings from clinical sequencing for arrhythmogenic right ventricular cardiomyopathy, presenting case studies exemplifying these challenges. They also propose a management approach for returning clinical genomic findings, and discuss new innovations in the light of precision medicine.                                                 We also published a review article by Pradeep Natarajan, Siddhartha Jaiswal, and Sekar Kathiresan from MGH on "Clonal Hematopoiesis Somatic Mutations in Blood Cells and Atherosclerosis", which discusses recent advances in our knowledge on the role of somatic mutations in cardiovascular disease risk.                                                 Finally, we have an update on some pharmacogenomics research into CYP2C19 Genotype-Guided Antiplatelet Therapy by Craig Lee and colleagues which we published a few months ago. Dr. Lee was also featured on Podcast episode 15 in April of this year.                                                 Jernice Aw and colleagues from Khoo Teck Puat Hospital, Singapore shared from complimentary data from their sample of 247 Asian subjects which found the risk for major adverse cardiovascular events was over 30-fold greater for poor metabolizers, as defined by CYP2C19 genotype on clopidogrel, as compared to those with no loss of function allele.                                                 You can read that letter and the response from Dr. Lee and colleagues online now. And, as usual, all of the original research articles come with an editorial to help give some more background and perspective to each paper. Go to circgenetics.ahajournals.org to find all the papers and to access video summaries and more.                                                 Our interview is with Dr. Sumeet Khetarpal who recently completed his MD-PhD training at the University of Pennsylvania, and is currently a resident in Internal Medicine at Massachusets General Hospital. Sumeet kindly took some time out from his busy residency schedule to talk to me about his recently published paper, and to explain how molecular inversion probe target capture actually works.                                                 So I am here with Dr. Sumeet Khetarpal who is co-first author on a manuscript entitled, "Multiplexed Targeted Resequencing Identifies Coding and Regulatory Variation Underlying Phenotypic Extremes of High-Density Lipoprotein Cholesterol in Humans."                                                 Welcome Sumeet, thanks for taking the time to talk to me. Dr. Khetarpal:                    Thank you so much Dr. Ferguson, it's really a pleasure to talk to you today. Jane:                                     Before we get started, maybe you could give a brief introduction on yourself and then how you started working on this paper. Dr. Khetarpal:                    Sure, so this work actually was a collaboration that came out at the University of Pennsylvania that I was involved with through my PhD thesis lab, my mentor was Dan Rader, and also a lab that is a somewhat newer lab at Penn, Benjamin Voight's lab which is a strong sort of computational genomic lab.                                                 This work actually highlights the fun of collaborating within your institution. We had, for some time, been interested in developing a way to sequence candidate genes. Both known genes and also new genes that have come out of genome-wide association studies that underlie the extremes of HDL cholesterol, namely very high cholesterol versus low HDL cholesterol. We've been looking for a cost-effective and scalable way to do this.                                                 Independently, Ben, who is very interested in capturing the non-coding genome, was interested in developing a method to better understand the non-coding variation, both common and rare variation that may be present at all of these new loci that have come out for complex traits such as HDL.                                                 We, at some Penn event several years ago, were talking about our common interest and Ben had actually identified this work that had come out of J. Shendure's lab at the University of Washington. A paper by the first author, Brian O'Rouke, in Science in 2012 in which they had developed an approach that involved molecular inversion probes, or MIPs, to capture regions of the genome related to target the gene that they were interested in studying for autism-spectrum disorders.                                                 They had applied this largely to coding regions of, I think, almost 50 genes and almost 2,500 patients with the feedback to do deep, targeted sequencing. So our thought was, well, we could try to apply this approach and adapt it to capture non-coding regions, and also see if we can expand the utility of this approach to study the phenotypic extremes of a complex trait such as HDL cholesterol. Jane:                                     Yeah, that's really cool. I love how you saw this method in a totally different application and then realized that there was expertise at Penn that you could bring together to apply this in a different way.                                                 I'd love to hear more about this MIP, the molecular inversion probe. How does it work? How difficult is it to actually do? Is it very different from normal library preparation for sequencing or is it something that's actually relatively easy to apply? Dr. Khetarpal:                    These MIP probes are oligonucleotide probes that capture your region of interest by flanking them and capturing by gap filling. There's a method to capture parts of the genome in a library-free way. They do ultimately involve barcoding the way traditional library-based target capture does and then deep sequencing.                                                 But the most impressive feature about them is just that they're very scalable. I think in the original paper by O'Rouke and colleagues they were able to sequence their set of genes and their set of samples at about a sample preparation cost of $1 per sample, and we were actually able to do about the same for our study.                                                 The main utility of the approach is just the economic scalability, and the ability to customize your panel to capture several regions of the genome that are adjacent to each other. Jane:                                     Right, so how many genes or regions can you multiplex at the same time? Is it just one prep, like you just design all of your oligos, you put them all together in one reaction, or are you doing separate reactions for each region? Dr. Khetarpal:                    We're actually doing all of our oligos together. In our case, I think it ended up being around the order of almost 600 oligos together to capture our ultimately 50kB of genomic territory that we wanted to capture. Really, our study was kind of a pilot experiment where we picked a few genes or regions of high interest to us, both known genes that effect HDL and also those that have been implicated in genome-wide association studies that were of high interest to our labs.                                                 I think that this approach could actually be expanded to capture much more genomic territory in a single capture reaction. We sort of touched the surface probably of what we could do. Jane:                                     Wow, that's cool! And then for sequencing it, I guess it's really just a function of how many samples you wanna multiplex and how much you want to sequence from each region. So I suppose the way you did it, you had about 50kB and then you had over 1,500 participants and you were able to do those on a single HiSeq run, right? Dr. Khetarpal:                    Right. Jane:                                     So I suppose if you'd done more genetic regions, you would've had fewer people and vice versa so you can balance that out depending on if you're having more samples or more genomic regions to sequence. Dr. Khetarpal:                    Exactly, in certain ways the design of our experiment we had a limited sample size that did afford us some luxury in terms of knowing that we would have deep coverage of the region that we were targeting. I think that's always a critical question in sort of targeted or just sequencing in general. The balance between the number of regions that you want to sequence and the number of samples you want to sequence is going to dictate what your sequencing depth with be. Jane:                                     Right, okay so I guess if we go on to what you actually found, how'd you pick this? You picked seven regions which encompasses eight candidate genes for HDL, so how did you select those? Dr. Khetarpal:                    The population that we were studying, the samples we were looking to sequence were largely individuals which fall into two bins if you will. One was extremely high HDL cholesterol which we're defining as the greater than the 95th percentile, but really there was a range within that population that spanned individuals with probably greater than the 99th percentile of HDL.                                                 We were hoping as a proof of principle effort to identify variation in genes that were known causes of high HDL cholesterol in prior studies of Mendelian genes for HDL. So genes such as LIP gene which encodes endothelial lipase or CETP or SCARB1, these 3 genes are, at this point, well-known genes that loss of function mutations are associated with extremely high HDL. We thought that capturing some of those genes would potentially both provide a level of validation for the approach, hypothesizing that individuals with high HDL would be enriched with these genes, but also may allow us to find new variants in these genes or also non-coding variants which has not previously been studied before.                                                 Some of the genes came out from that line of thinking, then some of the other genes happened to be genes that in the Rader laboratory we had a vested interest in understanding the genetic variation that might link the genes to HDL, which may not have necessarily come out before.                                                 For example, the gene GALNT2 is one of the first g-loss implicated novel genes for HDL, novel as in the earliest g-loss study for plasma lipids had identified that gene as associated with HDL but it never had come out before as being so. Our laboratory was very interested in better understanding the genetic relationship between genes such as GALNT2 and several of the others such as CCDC92 and ZNF664 with HDL.                                                 It ended up being a hodge-podge or a sampling of genes that had at some level been implicated with HDL, but really it's just a proof of principle that this method could work for both identifying variation in known genes and also less studied ones. Jane:                                     You validated the MIP genotyping by exome genotyping, and then saw concordance of over 90%, is that lower than you were expecting? Was it about what you were expecting based on these two different methods of genotyping? Dr. Khetarpal:                    Yes, I think we were expecting somewhere on the order of 90 plus percent. It's hard to know why we just hit that, we likely would've benefited from being able to genotype all of the individuals by the exome chip that we had sequenced as well, where we were able to validate in about two-thirds of those individuals.                                                 It's hard to know exactly what the cause of the about 10% discordance rate might be, whether it's just in certain samples the genotyping quality was perhaps on the border of being valid or the sequencing quality. Jane:                                     Right, I'm wondering sort of with the MIP, what's the gold standard? Is the XM chip genotyping still the gold standard and the MIP maybe is more error-prone, or perhaps the other way around? Or is it you can't tell at this point which is the true genotype and which is an error potentially for those discordant ones? Dr. Khetarpal:                    Certainly whenever there's a new sequencing methodology that is proposed I think it's critical to have some sort of validation. We happened to cover regions that would span the genome enough that we had XM chip genotyping in a large subset, that that might be the best approach. But if you had a limited number of regions or variance that you were interested in one could imagine also doing Sanger sequencing as the tried and tested validation approach. Of course it becomes not so scalable at a certain point.                                                 Certainly we would say that the MIPs, while the method has been developed and expanded by the Shendure lab, our hope is that through our studies maybe it will be applied further. It's still very much a new approach and so validation is key. Jane:                                     Very important. What do you think was the most exciting finding that came out of this, after you analyzed the data, what were you most excited about seeing? Dr. Khetarpal:                    The critical finding for us, which I think implies the utility of the approach, was just the validation of four of the loci that we had studied. Validation in our cohort of known genome-wide significant associations for HDL that had been published previously in almost 200,000 individuals in terms of sample size, in our experiment involving just about 1,500 people we were able to find consistent associations of those same variants that segregated with low versus high HDL. Directionally consistent with the large genome-wide association studies.                                                 I think the value of this finding is really just to emphasize the utility of the case control design in these phenotypic extremes, in addition to the overarching goal of our study, which was in a way that perhaps provides the most validation of the approach in terms of concordance with prior known studies. Jane:                                     So if somebody was listening to this and was trying to decide should they use MIP for a study they have in mind, should they use another technique? Based on your experience, what would you recommend? Dr. Khetarpal:                    I think in our current stage it's a very exciting time because we're just seeing whole genome sequencing really take off and being used at scale to ask critical questions about non-coding variation as it relates to both disease and complex traits. I don't think we're quite there yet with being able to apply that approach in a cost effective manner. The ability to annotate and analyze that data is still at it's infancy. The utility of the MIPs is that it provides a very cheap alternative.                                                 I can say from my experiences actually doing the capture and preparation from sample to sequencer stage that it's a very easy to use methodology that is very fast and cheap. That if one is really interested in a handful, or more than a handful, of candidate genes and their non-coding regions as it relates to a trait or disease of interest, it may not be the era for going full on with whole genome sequencing, especially at the current cost. That's where I think the MIPs really come in to be very useful. Jane:                                     It sounds great, is there anything else that you'd like to mention? Dr. Khetarpal:                    Just to say that we recognize it's a relatively small study as our pioneer approach with this method but that the Rader lab and Voight labs are actively pursuing larger applications of this to study, not only HDL, but other complex traits, such as diabetes, in much larger populations. I can't overemphasize how easy of a method it is to apply, but also that I think a bigger take home of this study for me as a very recent graduate student working in a very collaborative institution the ability of two laboratories to come together with different sets of expertise to try to tackle a problem that I think goes beyond the individual science. For any human geneticist how to find the variation you're interested in and not break the bank is kind of at the core of what we do, and so I think it was very fun to be part of this collaboration and our hope is that the outcome of it is a method that can be useful for many people, both in our field and beyond. Jane:                                     I think it's great and I'm hoping this will inspire a lot of other people to try this method and see if it can work for them. So, congratulations on the study, it's really nice work. Dr. Khetarpal:    Thank you so much!                                                                                                                                       Jane:                                     That's all I have for you for July, thanks for listening. Send me your thoughts on the podcast via Twitter or email, or leave us a review in Itunes. I look forward to talking to you next month.  

Introduction Welcome to another edition of Portable Practical Pediatrics! I'm your host Dr. Paul Smolen, also known as Doc Smo. From gestation all the way to graduation, if it involves children, we discuss it here. Today we are going to take on the question of what trait or traits make a great physician? How do you know if you have a just an average pediatrician or you've got one that is a cut above? Are the best doctors the ones that got the highest scores on exams in med school or the ones who have seen the most patients? Or are the best doctors the ones that are the friendliest, best looking, and have the best bedside manner? Since I have been practicing and teaching pediatrics now going on 36 years, the question of good doctoring traits is one that I have pondered for some time. Certainly, excellence involves a lot of factors but here is what I have concluded after a my long career in medicine; the doctors who are the best observers, take sufficient time and attention to get a thorough understanding of the child's symptoms, and then judiciously do testing to either confirm or deny their conclusions--those are the best physicians. In short, the best physicians are the ones that are the best listeners. The famous physician of the 19th century, William Osler who help found the Johns Hopkins Medical Center, said it best when he remarked, "Listen to your patient, he is telling you the diagnosis." In medicine, this is called getting a good history.  Today we are going to explore the art of diagnosis from a doctor's perspective. I am going to pull the curtain back on the diagnostic process behind your child's visit to the pediatrician and explore things you can do to maximize the value of your child's next visit to their health care provider. Musical Intro Most parents are really good observers. I have found that most parents are excellent observers of their children and their physical symptoms. Most can give an accurate, detailed, and useful description of their children's signs and symptoms. I must say however, that this is often more true of Mom's than it is of Dad's. Generally speaking, mothers can give a more accurate description than can fathers because they often, spend more time with their children. That only makes sense to me. Now here is something to consider before your child's next pediatric visit; Doc Smo Pearl: "Anything that gets in the way of your pediatrician's careful history taking process weakens your child's visit."  This reality is particularly important when a child is brought to the doctor for a more complex problem such as chronic stomachaches, a prolonged fever, or an unusual rash. Asking the right questions, getting an accurate description of the child's symptoms, and carefully listening to their answers is what good medicine is all about and what the best doctors do well.  Being a good doctor is synonymous with being a good engaged listener and observer. Things that get in the way of a good history: But parents need to understand that there are many things that can get in the way of their pediatrician being able to obtain a really good and accurate history. Let's go through a few of them: -Multiple children at a visit-You can imagine the scene-- 4 kids of various ages in am 8X10 exam room, fighting over a few books or toys. This often means chaos and not only is the doctor distracted from the issue at hand, but so is the parent history giver. -A very anxious or exhausted parent-These emotional states often distort and hinder a parent's accurate recall of their child's symptoms. Additionally, now, instead of focusing on the child and their symptoms, the pediatrician is now dealing with Mom or Dad's anxiety rather than the symptom at hand. In these situations, much of my energy is going toward defusing the parent's emotional state rather than learning more about the child's symptom. -Similarly, a parent who is mad at whoever or whatever is often not able to describe their child's sympto...

On this season of Working, we visit the city of Baltimore, to talk to people about their jobs there. We're hoping to learn about how the city informs their work, and how they are shaping Baltimore itself, by working. When Harry Mushlin operates on a brain, he feels his patient's selfhood in his hands. Mushlin is a neurosurgery resident with the University of Maryland currently practicing pediatric neurosurgery at Johns Hopkins Medical Center and operating on victims of violence at UMD's Shock Trauma Center. He spoke with us about working on the human brain, the trying hours of neurosurgery, and seeing Baltimore through the lens of the operating room. Then in a Slate Plus Extra, Mushlin tells us about working in the shadow of Baltimore's most famous neurosurgeon, Dr. Ben Carson. If you’re a member, enjoy bonus segments and interview transcripts from Working, plus other great podcast exclusives. Start your two-week free trial at slate.com/workingplus. Email: working@slate.com Twitter: @Jacob_Brogan Learn more about your ad choices. Visit megaphone.fm/adchoices

On this season of Working, we visit the city of Baltimore, to talk to people about their jobs there. We're hoping to learn about how the city informs their work, and how they are shaping Baltimore itself, by working. When Harry Mushlin operates on a brain, he feels his patient's selfhood in his hands. Mushlin is a neurosurgery resident with the University of Maryland currently practicing pediatric neurosurgery at Johns Hopkins Medical Center and operating on victims of violence at UMD's Shock Trauma Center. He spoke with us about working on the human brain, the trying hours of neurosurgery, and seeing Baltimore through the lens of the operating room. Then in a Slate Plus Extra, Mushlin tells us about working in the shadow of Baltimore's most famous neurosurgeon, Dr. Ben Carson. If you’re a member, enjoy bonus segments and interview transcripts from Working, plus other great podcast exclusives. Start your two-week free trial at slate.com/workingplus. Email: working@slate.com Twitter: @Jacob_Brogan Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Michelle Reina discusses how to build trust among team members and why it's so important that we do so. You'll Learn:The three key components that define trustWhat trusting and untrusting behaviors look like in practiceWhat you can do to identify trusting relationships and develop ones lacking in trustAbout MichelleDr. Michelle Reina and Dr. Dennis Reina, cofounders of The Reina Trust Building Institute, are leading authorities on helping leaders build, rebuild and sustain trust to produce business results. Over the last 17 years, their research and consulting practice has supported such organizations as American Express, Boeing, Johnson & Johnson, Microsoft, Toyota, Walt Disney World, US Army Chaplaincy, US Dept of Education, Johns Hopkins Medical Center, Harvard & Yale Universities, and many others. Their bestselling work, Trust & Betrayal in the Workplace won the 2007 Nautilus Book Award and the 2008 Axiom Book Award. Rebuilding Trust in the Workplace was awarded the 2011 Axiom Book Award.Items Mentioned in this Show:Website: reinatrustbuilding.comBook: Trust & Betrayal in the Workplace: Building Effective Relationships in Your Organization by Dennis Reina and Michelle ReinaBook: Rebuilding Trust in the Workplace: Seven Steps to Renew Confidence, Commitment, and Energy by Dennis Reina and Michelle ReinaView transcript, show notes, and links at https://awesomeatyourjob.com/ep62See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Michelle Reina discusses how to build trust among team members and why it’s so important that we do so. You’ll Learn: The three key components that define trust What trusting and untrusting behaviors look like in practice What you can do to identify trusting relationships and develop ones lacking in trust About Michelle Dr. Michelle Reina and Dr. Dennis Reina, cofounders of The Reina Trust Building Institute, are leading authorities on helping leaders build, rebuild and sustain trust to produce business results. Over the last 17 years, their research and consulting practice has supported such organizations as American Express, Boeing, Johnson & Johnson, Microsoft, Toyota, Walt Disney World, US Army Chaplaincy, US Dept of Education, Johns Hopkins Medical Center, Harvard & Yale Universities, and many others. Their bestselling work, Trust & Betrayal in the Workplace won the 2007 Nautilus Book Award and the 2008 Axiom Book Award. Rebuilding Trust in the Workplace was awarded the 2011 Axiom Book Award. View transcript, show notes, and links at http://AwesomeAtYourJob.com/ep62

Ryan Andrews is a competitive bodybuilder turned registered dietitian, yoga instructor, and volunteer organic farmhand, Ryan trained at Johns Hopkins Medical Center, Kent State University, and the University of Northern Colorado. He’s authored/co-authored several books and has worked with Precision Nutrition for 7 years. Ryan joins the LLA Show to discuss the following:     How did Ryan transition from a bodybuilding lifestyle to a life focused on volunteering, plant-based eating, and focusing on the needs of others What are some of the biggest mistakes many make when transitioning to a plant-based diet Ryan shares his views of folks new to plant-based eating who may get caught up in the "social media diet savior" complex How does Ryan address those who focus too much on the macro aspect of a plant-based diet How does Ryan address the proverbial "protein" question What are the key points that Ryan recommends to clients focusing on a plant-based diet What is Ryan's opinion of supplements How does Ryan address clients who may have issues with lectins and digestive issues  What are the top nutrient deficiencies Ryan sees in those who follow a plant-based diet & how does he address this issue Ryan shares how he got involved with volunteer work in Africa and how he helped shape his current outlook of life   All this and much more:   Links & Resources mentioned in the show: Keep the LLA Podcast free. Become a monthly supporter via $5 or more on Patreon: http://www.patreon.com/llapodcast Warrior Angels Foundation:  http://warriorangelsfoundation.org Purchase Aggressive Strength products: http://strengthbymahler.com Purchase Aggressive Strength Bundles:  http://budurl.com/mahlerbundles Purchase New Warrior Training products: http://newwarriortraining.com Sincere's Top 5 coffee suggestions: http://newwarriortraining.com/coffeestands/ Ryan Online: www.precisionnutrition.com/coach-profile-ryan-andrews     Listen and download at http://strengthbymahler.com or http://newwarriortraining.com.  also subscribe, download, rate & review us at: iTunes: https://itunes.apple.com/us/podcast/live-life-aggressively-podcast/id646524617  Stitcher: http://www.stitcher.com/s?fid=34706&refid=stpr Also, be sure to "like" and connect with us on our Facebook fan page at http://facebook.com/llapodcast.  

Get the OFF TO WORK CD by Sister Jenna.  Like America Meditating on FB & Follow us on Twitter. Dr. Bob Deutsch is a cognitive neuroscientist, cultural anthropologist, and founder and president of Brain Sells, a company that develops breakthrough strategies for businesses and brands based on wide-ranging and research-based insights into human cognition and social behavior. He founded the company after years of studying how people in many different cultures and countries create beliefs and attachments — how leading ideas take hold. His insights into human behavior have made him a valuable asset to the State Department and the Department of Defense.  His commercial clients have included MasterCard, Apple and The Johns Hopkins Medical Center.   Dr. Deutsch has contributed articles on human nature, the cultural moment and marketing to The Atlanta Journal-Constitution, The Chicago Tribune and The National Geographic Magazine. His commentaries have appeared on ABC's Nightline and Good Morning America, and on the PBS series, Rights & Wrongs. He also lectures and is on the roster of the Leading Thoughts Speakers Bureau. His new book is entitled, "The 5 Essentials: Using your Inborn Resources to Create a Fulfilling Life.".  Visit his website at www.brain-sells.com  

Johns Hopkins Medical Center has a sophisticated difficult airway response team which we decided to model at Yale. Lauren Berkow, MD, the co-director of the team talks about its history and logistics

Jennifer Jones, MSW, LCSW is a licensed clinical social worker. She has a passion for working with individuals and couples in helping them increase their self awareness, their understanding of their family of origin as well as helping them enhance their connections and relationships with others. Jennifer specializes in communication enhancement, premarital counseling, blended family issues, parent/adult-child relationships, grief and loss, and infidelity. Jennifer received her Certificate in Marriage and Family Therapy at Council for Relationships and her Masters of Social Work from the School of Social Policy and Practice at the University of Pennsylvania. http://www.councilforrelationships.org/index.shtml Shane K. Perrault, PhD is a psychologist and coach with more than 16 years of experience. Dr. Shane received his doctorate in Clinical Psychology from the Ohio State University and did his residency at Johns Hopkins Medical Center and the Baltimore Veterans Administration. In addition to maintaining a thriving practice in Silver Spring, MD, he has conducted workshops and training in the MD/DC/VA area on topics including effective communication and conflict resolution. http://www.adhdpc.com/

The 10th Annual Rhoda Goldman Lecture in Health Policy presents Alfredo Quiñones-Hinojosa, Associate Professor of Neurosurgery and Oncology at Johns Hopkins Medical Center. Named as one of the 100 most influential Hispanics in 2008, Dr. Quinones-Hinojosa’s third book, “Becoming Dr. Q – My Journey from Migrant Farm Worker to Brain Surgeon,” comes out in fall 2011. Series: "Richard and Rhoda Goldman School of Public Policy at UC Berkeley" [Public Affairs] [Health and Medicine] [Show ID: 22768]

The 10th Annual Rhoda Goldman Lecture in Health Policy presents Alfredo Quiñones-Hinojosa, Associate Professor of Neurosurgery and Oncology at Johns Hopkins Medical Center. Named as one of the 100 most influential Hispanics in 2008, Dr. Quinones-Hinojosa’s third book, “Becoming Dr. Q – My Journey from Migrant Farm Worker to Brain Surgeon,” comes out in fall 2011. Series: "Richard and Rhoda Goldman School of Public Policy at UC Berkeley" [Public Affairs] [Health and Medicine] [Show ID: 22768]

The 10th Annual Rhoda Goldman Lecture in Health Policy presents Alfredo Quiñones-Hinojosa, Associate Professor of Neurosurgery and Oncology at Johns Hopkins Medical Center. Named as one of the 100 most influential Hispanics in 2008, Dr. Quinones-Hinojosa’s third book, “Becoming Dr. Q – My Journey from Migrant Farm Worker to Brain Surgeon,” comes out in fall 2011. Series: "Richard and Rhoda Goldman School of Public Policy at UC Berkeley" [Public Affairs] [Health and Medicine] [Show ID: 22768]

The 10th Annual Rhoda Goldman Lecture in Health Policy presents Alfredo Quiñones-Hinojosa, Associate Professor of Neurosurgery and Oncology at Johns Hopkins Medical Center. Named as one of the 100 most influential Hispanics in 2008, Dr. Quinones-Hinojosa’s third book, “Becoming Dr. Q – My Journey from Migrant Farm Worker to Brain Surgeon,” comes out in fall 2011. Series: "Richard and Rhoda Goldman School of Public Policy at UC Berkeley" [Public Affairs] [Health and Medicine] [Show ID: 22768]

***NOTE: Lamar Tyler and Nisa Muhammad were unable to make the show today due unexpected circumstances. I will try to resedule them for another day. SPECIAL GUEST: Shane K. Perrault, PhD is a psychologist and coach with more than 16 years of experience. Dr. Perrault received his doctorate in Clinical Psychology from the Ohio State University and did his residency at Johns Hopkins Medical Center and the Baltimore Veterans Administration. Official Blogger for Psychology Today Magazine. Dr. Perrault is the founder and Lead Psychologist at the ADHD Performance Counseling Center in Silver Springs, MD. http://www.adhdpc.com SPECIAL GUEST: As a certified marriage and family therapist, Dr. Peggy Vertreace incorporates the inter-relatedness of mind, body, and spirit into her therapeutic approach, which is influenced not only by her clinical and theoretical perspective, but also by her strong theological foundation. Peggy earned her Doctor of Ministry in Marriage and Family from Palmer Theological Seminary of Eastern University, and completed her post-graduate training from Council for Relationships in Marriage and Family Therapy. Peggy is a certified Master level instructor of the PAIRS (Practical Application of Intimate Relationships Skills) Program couples.www.councilforrelationships.prg

SPECIAL GUEST: Shane K. Perrault, PhD is a psychologist and coach with more than 16 years of experience. Dr. Perrault received his doctorate in Clinical Psychology from the Ohio State University and did his residency at Johns Hopkins Medical Center and the Baltimore Veterans Administration. Dr. Perrault is the Lead Psychologist at the ADHD Performance Counseling Center in Silver Springs, MD. Website: http://www.adhdpc.com. SPECIAL GUEST Dr. Josephine Elia, Co-Medical Director of Children's Hospital of Philadelphia's Center for Management of ADHD. (website: http://www.chop.edu/consumer/jsp/division/generic.jsp?id=70606) She attended Medical College of Pennsylvania. Board Certified in Psychiatry and Child and Adolescent Psychiatry. Special Interests: include: ADHD, Tic disorders/Tourette syndrome, Obsessive-compulsive disorder and sleep problems.

Where are they? What makes a good father? Single Fathers. Teen Fathers. What challenges do they face? Race, Economics, Incarceration, Drugs, Emotional. SPECIAL GUEST: Bilal Qayyum, President of the Father's Day Rally Committee, Inc. Some of Mr. Qayyum's Awards include: Tribune 2005 and 2006 , 2007 Philadelphia's Most Influential African Americans Leaders, The Chapel of Four Chaplains Legion of Honor, and KYW-3 Making a Difference. SPECIAL GUEST: Reverend Rodney DeWitt Rogers is the Senior Pastor of Christ of Calvary Covenant Church at 500 South 61st Street in Philadelphia, Pennsylvania. Pastor Rogers is committed to facilitating the creative spiritual transformation of urban communities through collaborative leadership in academically based programs and services that combine interdisciplinary engagement of communities of faith, colleges, universities, seminaries, and neighborhood organizations. SPECIAL GUEST:Shane K. Perrault, PhD is a psychologist and coach with more than 16 years of experience. Dr. Shane received his doctorate in Clinical Psychology from the Ohio State University and did his residency at Johns Hopkins Medical Center and the Baltimore Veterans Administration. In addition to maintaining a thriving practice in Silver Spring, MD, he has conducted workshops and training in the MD/DC/VA area on topics including effective communication and conflict resolution.

Host: Michael Greenberg, MD Guest: Adrian Dobs, MD Dr. Michael Greenberg speaks with Dr. Adrian Dobs, the director of the Center for Complementary and Alternative medicine at Johns Hopkins Medical Center, about their research projects and how they integrate standard and alternative medicine in patient care.

Host: Michael Greenberg, MD Guest: Adrian Dobs, MD Dr. Michael Greenberg speaks with Dr. Adrian Dobs, the director of the Center for Complementary and Alternative medicine at Johns Hopkins Medical Center about research projects integrating standard and alternative medicine in patient care.